Evidence map›Paper›PMID 40256723›Full record

ArticleChinese herbal medicines2025

MYB polymorphism molecular marker: A novel molecular marker for authenticity and geographical origin identification of

Qiqing Cheng, Ziyu Tang, Yue Ouyang, Chunsong Cheng, Chichou Lao, Hao Cui, Hua Zhou, Yongshu Liang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese herbal medicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiqing ChengSchool of Pharmacy, Hubei University of Science and Technology, Xianning 437100, China.
Ziyu TangState Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macao 999078, China.
Yue OuyangState Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macao 999078, China.
Chunsong ChengJiangxi Key Laboratory for Sustainable Utilization of Chinese Material Medical Resources, Lushan Botanical Garden, Chinese Academy of Science, Jiujiang 332900, China.
Chichou LaoState Key Laboratory of Quality Research in Chinese Medicine, Faculty of Chinese Medicine, Macau University of Science and Technology, Macao 999078, China.
Hao CuiKey Laboratory of Sustainable Utilization of Panax Notoginseng Resources of Yunnan Province, School of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China.
Hua ZhouChinese Medicine Guangdong Laboratory (Hengqin Laboratory), Guangdong-Macao In-Depth Cooperation Zone in Hengqin, Zhuhai 519031, China.
Yongshu LiangGuangdong Food and Drug Vocational College, Guangzhou 510520, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: We selected one of the most studied transcription factor families in Results: A total of ten MYB primers were screened out to identify Xinhui CRP from plants from different family ( Conclusion: This study established a novel molecular identification method according to MYB transcription factor, which can analyze the potential parental relationship of CRP germplasm, as well as identify the quality and origins of Xinhui CPR.

Indexed as

Citri Reticulatae Pericarpiumgenetic diversitygeographical origin identificationmolecular makerMYB transcription factor

Identifiers

PMID40256723
PMCPMC12009098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.